[Clinical study of a new cephalosporin, ceftriaxone (Rocefin Roche) in bronchopneumonia in children].
De Marco A, B Manca
Abstract
De Marco A, B Manca
Abstract
Ceftriaxone (Ro-13-9904) is a broad spectrum cephalosporin with a very long plasma half-life: about 8 h. We administered Ceftriaxone to 9 children suffering from bronchopneumonia. The clinical, X-ray and biochemical response were favourable in all cases.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ceftriaxone (Ro-13-9904) is a broad spectrum cephalosporin with a very long plasma half-life: about 8 h. We administered Ceftriaxone to 9 children suffering from bronchopneumonia. The clinical, X-ray and biochemical response were favourable in all cases.
Key concepts: Ceftriaxone, Cephalosporin, Bronchopneumonia, Medicine, Cephalosporin Antibiotic, Antibiotics, Internal medicine, Microbiology